Pressure BioSciences secures cosmeceuticals partnership for UST platform with Dr. Denese SkinScience

Pressure BioSciences, Inc. (OTCQB:PBIO) president and CEO Richard Schumacher joined Proactive’s Stephen Gunnion with details of a two-year Collaborative Research and Development Agreement with Dr. Denese SkinScience to use PBI’s unique Ultra Shear Technology (UST) nanoemulsification platform to enhance existing and develop new skincare products.

Schumacher telling Proactive that Dr. Denese SkinScience is one of the most successful, highly rated, award-winning, and longest-lasting skincare lines in the history of television shopping channel QVC.

It is the fourth agreement reached in the past few months for PBI’s technology, he added.

© 2022 Stockmark.it The Latest StockMarket News and Interviews